­ARRAY PLATFORM FOR HIGH-THROUGHPUT ORGANOID PROFILING

­ARRAY PLATFORM FOR HIGH-THROUGHPUT ORGANOID PROFILING

Researchers at Stanford have developed a new methodology for image processing that allows for high-throughput characterization of organoid phenotypes.

Organoids represent a major step forward in in vitro research studies into a myriad of disease states. 3D organoid models possess key advantages over conventional 2D cell culture models including a closer approximation of in vivo settings as well as a reduction of genomic background signal which in turn enables editing with CRISPR/Cas9 technology to further reproduce disease states. Current organoid construction involves resuspending aggregated cells in commercially available extracellular matrix (ECM) mimics, rather than from a single cell. Due to this property of their construction, it is difficult to determine whether an organoid phenotype has arisen from the stochasticity of the deposited cell population, or from an intrinsic property of individual cells. Single organoid phenotypic characterization remains a challenge.

Stage of Research

The inventors have identified a new microwell based technique for the high-throughput quantification of image-based parameters at single organoid resolution. This method can be used to phenotypically monitor thousands of organoids in parallel. Phenotypes such as organoid growth rates, migration behavior, and fluorescently labeled protein expression and localization are all parameters that can be assessed through this pipeline. Once profiled, organoids can be retrieved from their microwells for sequencing and molecular profiling to determine the genomic or proteomic origin of the organoid’s phenotypic state.

Applications

  • High-throughput drug screening of patient-derived human organoids
  • Characterization of genetic mutations of interest in parallel
  • Elucidation of genetic mutations that contribute to tumor microenvironments

Advantages

  • Organoid profiling is not restricted to bulk averages for parameters such as growth rates or division times.
  • Does not require specialized instrumentation and is therefore an easy addition to existing cell culture workflows.
  • Organoids can be generated from single cells rather than aggregated cell populations.

Stage of Development

Research- in vitro

Publications

Sockell, A., Wong, W., Longwell, S., Vu, T., Karlsson, K., Mokhtari, D., Schaepe, J., Lo, Y.-H., Cornelius, V., Kuo, C., Van Valen, D., Curtis, C.*, & Fordyce, P.M.*, “A microwell platform for high-throughput longitudinal phenotyping and selective retrieval of organoids”, Cell Systems (in press); bioRXiv (2022)

Related Web Links

http://www.fordycelab.com/53sb6umht3nidw20qa91xdkvkxvdm4

Keywords

Organoid, imaging, high throughput, CRISPR

Technology Reference

CZ Biohub ref. no. CZB-257S

Stanford ref. no. S22-238

 

Patent Information:
For Information, Contact:
CZBiohub Admin
CZ Biohub
ip@czbiohub.org
Inventors:
Polly Fordyce
Christina Curtis
Alexandera Sockell
Wing Wong
Keywords:
CRISPR
High-Throughput
Imaging
Organoid